February 24, 2026
GLP-1s have become a popular topic because of their important role in appetite regulation, blood sugar balance, and overall metabolic health
(2022) LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist for glycemic control and weight loss Cell Metabolism PubMed ID: 35839753 [3] Urva S
Semaglutide is the active pharmaceutical ingredient that has helped thousands of people lose and maintain weight loss in combination with diet and exercise
Tirzepatide commonly causes nausea, vomiting, diarrhea, and decreased appetite, particularly during initiation and dose escalation
Key drivers fueling this momentum include a strong product pipeline with innovative molecules and combination therapies, and increased healthcare spending in emerging economies